当前位置:
X-MOL 学术
›
Lancet Infect Dis
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A bedaquiline, pretomanid, moxifloxacin, and pyrazinamide regimen for drug-susceptible and drug-resistant tuberculosis
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2024-05-17 , DOI: 10.1016/s1473-3099(24)00257-3 Guofang Deng 1 , Liang Fu 1
中文翻译:
贝达喹啉、普托马尼、莫西沙星和吡嗪酰胺治疗药物敏感和耐药结核病的方案
更新日期:2024-05-17
The Lancet Infectious Diseases ( IF 36.4 ) Pub Date : 2024-05-17 , DOI: 10.1016/s1473-3099(24)00257-3 Guofang Deng 1 , Liang Fu 1
Affiliation
中文翻译:
贝达喹啉、普托马尼、莫西沙星和吡嗪酰胺治疗药物敏感和耐药结核病的方案